Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

119 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Hepatic decompensation in antiretroviral-treated patients co-infected with HIV and hepatitis C virus compared with hepatitis C virus-monoinfected patients: a cohort study.
Lo Re V 3rd, Kallan MJ, Tate JP, Localio AR, Lim JK, Goetz MB, Klein MB, Rimland D, Rodriguez-Barradas MC, Butt AA, Gibert CL, Brown ST, Park L, Dubrow R, Reddy KR, Kostman JR, Strom BL, Justice AC. Lo Re V 3rd, et al. Among authors: kallan mj. Ann Intern Med. 2014 Mar 18;160(6):369-79. doi: 10.7326/M13-1829. Ann Intern Med. 2014. PMID: 24723077 Free PMC article.
Predicting Risk of End-Stage Liver Disease in Antiretroviral-Treated Human Immunodeficiency Virus/Hepatitis C Virus-Coinfected Patients.
Lo Re V 3rd, Kallan MJ, Tate JP, Lim JK, Goetz MB, Klein MB, Rimland D, Rodriguez-Barradas MC, Butt AA, Gibert CL, Brown ST, Park LS, Dubrow R, Reddy KR, Kostman JR, Justice AC, Localio AR. Lo Re V 3rd, et al. Among authors: kallan mj. Open Forum Infect Dis. 2015 Jul 9;2(3):ofv109. doi: 10.1093/ofid/ofv109. eCollection 2015 Sep. Open Forum Infect Dis. 2015. PMID: 26284259 Free PMC article.
Risk of liver decompensation with cumulative use of mitochondrial toxic nucleoside analogues in HIV/hepatitis C virus coinfection.
Lo Re V Rd, Zeldow B, Kallan MJ, Tate JP, Carbonari DM, Hennessy S, Kostman JR, Lim JK, Goetz MB, Gross R, Justice AC, Roy JA. Lo Re V Rd, et al. Among authors: kallan mj. Pharmacoepidemiol Drug Saf. 2017 Oct;26(10):1172-1181. doi: 10.1002/pds.4258. Epub 2017 Jul 19. Pharmacoepidemiol Drug Saf. 2017. PMID: 28722244 Free PMC article.
HIV RNA, CD4+ Percentage, and Risk of Hepatocellular Carcinoma by Cirrhosis Status.
Torgersen J, Kallan MJ, Carbonari DM, Park LS, Mehta RL, D'Addeo K, Tate JP, Lim JK, Goetz MB, Rodriguez-Barradas MC, Gibert CL, Bräu N, Brown ST, Roy JA, Taddei TH, Justice AC, Lo Re V. Torgersen J, et al. Among authors: kallan mj. J Natl Cancer Inst. 2020 Jul 1;112(7):747-755. doi: 10.1093/jnci/djz214. J Natl Cancer Inst. 2020. PMID: 31687755 Free PMC article.
Brief Report: Accuracy of FIB-4 for Cirrhosis in People Living With HIV and Hepatocellular Carcinoma.
Torgersen J, Kallan MJ, Carbonari DM, Park LS, Mehta RL, D'Addeo K, Tate JP, Lim JK, Goetz MB, Rodriguez-Barradas MC, Bräu N, Brown ST, Taddei TH, Justice AC, Lo Re V 3rd. Torgersen J, et al. Among authors: kallan mj. J Acquir Immune Defic Syndr. 2020 Dec 15;85(5):530-534. doi: 10.1097/QAI.0000000000002510. J Acquir Immune Defic Syndr. 2020. PMID: 33185999 Free PMC article.
Differences in Pathology, Staging, and Treatment between HIV+ and Uninfected Patients with Microscopically Confirmed Hepatocellular Carcinoma.
Torgersen J, Taddei TH, Park LS, Carbonari DM, Kallan MJ, Mitchell Richards K, Zhang X, Jhala D, Bräu N, Homer R, D'Addeo K, Mehta R, Skanderson M, Kidwai-Khan F, Justice AC, Lo Re V 3rd. Torgersen J, et al. Among authors: kallan mj. Cancer Epidemiol Biomarkers Prev. 2020 Jan;29(1):71-78. doi: 10.1158/1055-9965.EPI-19-0503. Epub 2019 Oct 1. Cancer Epidemiol Biomarkers Prev. 2020. PMID: 31575557 Free PMC article.
Risk factors for lymphedema after breast cancer treatment.
Norman SA, Localio AR, Kallan MJ, Weber AL, Torpey HA, Potashnik SL, Miller LT, Fox KR, DeMichele A, Solin LJ. Norman SA, et al. Among authors: kallan mj. Cancer Epidemiol Biomarkers Prev. 2010 Nov;19(11):2734-46. doi: 10.1158/1055-9965.EPI-09-1245. Epub 2010 Oct 26. Cancer Epidemiol Biomarkers Prev. 2010. PMID: 20978176 Free PMC article.
The women in steady exercise research (WISER) survivor trial: The innovative transdisciplinary design of a randomized controlled trial of exercise and weight-loss interventions among breast cancer survivors with lymphedema.
Winkels RM, Sturgeon KM, Kallan MJ, Dean LT, Zhang Z, Evangelisti M, Brown JC, Sarwer DB, Troxel AB, Denlinger C, Laudermilk M, Fornash A, DeMichele A, Chodosh LA, Schmitz KH. Winkels RM, et al. Among authors: kallan mj. Contemp Clin Trials. 2017 Oct;61:63-72. doi: 10.1016/j.cct.2017.07.017. Epub 2017 Jul 21. Contemp Clin Trials. 2017. PMID: 28739540 Free PMC article. Clinical Trial.
Effect of Home-Based Exercise and Weight Loss Programs on Breast Cancer-Related Lymphedema Outcomes Among Overweight Breast Cancer Survivors: The WISER Survivor Randomized Clinical Trial.
Schmitz KH, Troxel AB, Dean LT, DeMichele A, Brown JC, Sturgeon K, Zhang Z, Evangelisti M, Spinelli B, Kallan MJ, Denlinger C, Cheville A, Winkels RM, Chodosh L, Sarwer DB. Schmitz KH, et al. Among authors: kallan mj. JAMA Oncol. 2019 Nov 1;5(11):1605-1613. doi: 10.1001/jamaoncol.2019.2109. JAMA Oncol. 2019. PMID: 31415063 Free PMC article.
119 results